Bandaram Pharma Packtech Ltd Financials
Company Logo

Bandaram Pharma Packtech Ltd Financial Statement

Bandaram Pharma Packtech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue2.72
Operating Expense2.97
Net Profit-0.25
Net Profit Margin-9.19
Earning Per Share-0.21
EBIDTA-0.25
Effective Tax RateTBA

Bandaram Pharma Packtech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Total Revenue Annual10.09
Operating Expenses Annual9.82
Operating Profit Annual0.27
Interest Annual0.00
Depreciation0.00
Net Profit Annual0.20
Tax Annual0.07

Bandaram Pharma Packtech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Cash Flow at the Beginning2.08
Cash Flow from Operations-3.87
Cash Flow from Investing-2.53
Cash Flow from Financing4.40
Cash Flow at the End0.09

Bandaram Pharma Packtech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
PBDIT Margin (%)2.68
PBIT Margin (%)2.68
PBT Margin (%)2.68
Net PROFIT Margin (%)1.98
Return On Networth / Equity (%)6.60
Return On Networth /Employed (%)5.16
Return On Assets (%)3.83
Total Debt / Equity (X)0.73
Asset Turnover Ratio (%)1.93

Bandaram Pharma Packtech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Fixed Assets Annual0.02
Total Current Assets Annual5.74
Non Current Assets Annual2.53
Total Shareholders Funds Annual3.07
Total Assets Annual8.27

Bandaram Pharma Packtech Ltd Earning Calls

EPS (INR)

Expected

0.15

Reported

0.15

Surprise

0.00%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 0.00%

Sep 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Sep 19, 2024, Bandaram Pharma Packtech Ltd has a market capitalization of 44.47 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Bandaram Pharma Packtech Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Bandaram Pharma Packtech Ltd recorded a total revenue of approximately 14.84 Cr marking a significant milestone in the company's financial performance.
Bandaram Pharma Packtech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and Infinity% annually, respectively..
Bandaram Pharma Packtech Ltd's current PE ratio is 342.08.
Bandaram Pharma Packtech Ltd's ROCE averaged 1.6% from the FY ending March 2022 to 2024, with a median of 1.4%. It peaked at 3.6% in March 2023, reflecting strong capital efficiency over the period..
Bandaram Pharma Packtech Ltd's latest EBIT is Rs. 0.17 Cr, surpassing the average EBIT of Rs. 0.14 Cr over the 5 years..